Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Completed2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (33.3%)
N/A2 (66.7%)

Trials by Status

not_yet_recruiting125%
recruiting125%
completed250%

Recent Activity

1 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

A Prospective Study on IVUS and DSA Guidance in the Treatment of Budd-Chiari Syndrome

NCT06960473
completed

Imaging-Guided Vessel Sizing in the Tibial Arteries

NCT04748965
recruitingnot_applicable

A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

NCT05718492
completedphase_1

Stellate Ganglion Block Using Ultrasound Guidance For Treatment Of Post Clipping Cerebral Vasospasm

NCT02775318

Clinical Trials (4)

Showing 4 of 4 trials
NCT06960473Not Applicable

A Prospective Study on IVUS and DSA Guidance in the Treatment of Budd-Chiari Syndrome

Not Yet Recruiting
NCT04748965

Imaging-Guided Vessel Sizing in the Tibial Arteries

Completed
NCT05718492Not Applicable

A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

Recruiting
NCT02775318Phase 1

Stellate Ganglion Block Using Ultrasound Guidance For Treatment Of Post Clipping Cerebral Vasospasm

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4